Format

Send to

Choose Destination
See comment in PubMed Commons below
Liver Int. 2016 Mar;36(3):317-24. doi: 10.1111/liv.13031. Epub 2015 Dec 25.

The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment.

Author information

1
Hepatology, Department of Clinical Research, University of Bern, Bern, Switzerland.
2
University Clinic for Visceral Surgery and Medicine, Inselspital, University of Bern, Bern, Switzerland.

Abstract

BACKGROUND & AIMS:

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. An increasing number of reports describe HCC in the setting of obesity and diabetes, two major risk factors for non-alcoholic fatty liver disease (NAFLD). The increasing incidence of these conditions and the emerging evidence of HCC in non-cirrhotic NAFLD prioritize a better understanding of NAFLD-related HCC epidemiology and pathogenesis in order to target screening policies and develop preventive-therapeutic strategies. In this review, we focus on the epidemiological impact of this condition, suggesting a possible link between HCC in cryptogenic cirrhosis and NAFLD. Furthermore, we analyse the suggested pathogenic mechanisms and the possible preventive-therapeutic strategies.

KEYWORDS:

HCC; NAFLD; diabetes; obesity

PMID:
26601627
DOI:
10.1111/liv.13031
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center